Returns Chart

Key Stats

Net Expense Ratio Total Assets Under Management Weighted Average Dividend Yield Turnover Ratio (Generic)
0.55% 1.253B 1.22% 26.00%
1 Year Fund Level Flows 1 Year Total Returns (Daily) Annualized Total Returns Since Inception (Daily) Max Drawdown (Since Inception)
47.51M 17.02%

Basic Info

Investment Strategy
The Fund seeks to equal the performance of the Standard & Poor's MidCap 400 Composite Stock Index ("S&P MidCap 400 Index"). The Index consists of common stock of approximately 400 mid capitalization companies. The Fund seeks to purchase stock of all the companies in the Index.
General
Security Type Insurance Fund
Equity Style Small Cap Core
Broad Asset Class US Equity
Broad Category Equity
Global Peer Group Equity US Sm&Mid Cap
Peer Group S&P Midcap 400 Index Funds
Global Macro Equity North America
US Macro Mid-Cap Funds
YCharts Categorization --
YCharts Benchmark --
Prospectus Objective Mid-Cap Funds
Fund Owner Firm Name Brighthouse Financial
Broad Asset Class Benchmark Index
^SPXTR 100.0%

View Basic Info
Start Trial

Net Fund Flows Versus Peer Group

View Net Fund Flows. Upgrade now.
1M
3M
6M
YTD
1Y
3Y
5Y
10Y
 
80.00B
60.00B
40.00B
20.00B
0
-20.00B
1 Month
% Rank: 65
-130.61M Peer Group Low
421.95M Peer Group High
1 Year
% Rank: 10
47.51M
-1.365B Peer Group Low
1.334B Peer Group High
3 Months
% Rank: 72
-566.32M Peer Group Low
1.145B Peer Group High
3 Years
% Rank: 36
-1.691B Peer Group Low
11.34B Peer Group High
6 Months
% Rank: 74
-315.29M Peer Group Low
2.167B Peer Group High
5 Years
% Rank: 44
-3.349B Peer Group Low
17.26B Peer Group High
YTD
% Rank: --
-566.32M Peer Group Low
1.145B Peer Group High
10 Years
% Rank: 36
-8.888B Peer Group Low
23.70B Peer Group High
Date Unavailable

Performance Versus Peer Group

 
20%
15%
10%
5%
0
Name
1M
3M
YTD
1Y
3Y
5Y
10Y
15Y
Total Return (NAV)
12.00%
12.00%
12.00%
12.00%
12.00%
12.00%
12.00%
12.00%
Peer Group Rtn. (NAV)
12.00%
12.00%
12.00%
12.00%
12.00%
12.00%
12.00%
12.00%
% Rank in Peer Group (NAV)
5.0
5.0
5.0
5.0
5.0
5.0
5.0
5.0
View Performance Versus Peer Group
Start Trial

Annual Total Returns Versus Peers

Loading chart...
Name
2019
2020
2021
2022
2023
2024
2025
YTD
31.49%
18.40%
28.71%
-18.11%
26.29%
25.02%
17.88%
-3.64%
25.99%
13.36%
24.50%
-13.25%
16.28%
13.70%
7.32%
3.30%
29.95%
16.67%
22.17%
-17.62%
16.83%
14.80%
10.18%
1.91%
25.85%
13.24%
24.45%
-13.25%
16.16%
13.64%
7.23%
3.39%
26.02%
13.43%
24.38%
-13.22%
16.16%
13.60%
7.22%
3.33%
As of April 02, 2026.

Fundamentals

General
Distribution Yield --
Dividend Yield TTM (4-1-26) 0.88%
30-Day SEC Yield --
7-Day SEC Yield --
Number of Holdings 407
Stock
Weighted Average PE Ratio 31.57
Weighted Average Price to Sales Ratio 4.660
Weighted Average Price to Book Ratio 5.261
Weighted Median ROE 16.59%
Weighted Median ROA 5.79%
ROI (TTM) 9.40%
Return on Investment (TTM) 9.40%
Earning Yield 0.0451
LT Debt / Shareholders Equity 1.035
Number of Equity Holdings 401
As of February 28, 2026

Growth Metrics

EPS Growth (1Y) 18.06%
EPS Growth (3Y) 10.29%
EPS Growth (5Y) 14.73%
Sales Growth (1Y) 9.33%
Sales Growth (3Y) 7.81%
Sales Growth (5Y) 12.00%
Sales per Share Growth (1Y) 62.80%
Sales per Share Growth (3Y) 7.03%
Operating Cash Flow - Growth Rate (3Y) 20.55%
As of February 28, 2026

Asset Allocation

As of February 28, 2026.
Type % Net
Cash -0.07%
Stock 98.81%
Bond 1.22%
Convertible 0.00%
Preferred 0.00%
Other 0.04%
View Asset Allocation
Start Trial

Top 10 Holdings

Name % Weight Price % Change
State Street SPDR S&P MidCap 400 ETF Trust 2.07% 621.79 0.82%
United States of America USGB 01/15/2026 FIX USD Government (Matured) 1.73% 100.00 0.00%
MID E-MINI MAR26
1.73% -- --
Ciena Corp. 0.99% 415.39 7.00%
Coherent Corp. 0.87% 247.80 4.03%
Lumentum Holdings, Inc. 0.78% 764.65 8.81%
Flex Ltd. 0.67% 68.24 4.25%
Twilio, Inc. 0.65% 130.46 3.69%
United Therapeutics Corp. 0.63% 570.27 -3.83%
Everpure, Inc. 0.63% 61.07 3.44%

Fees & Availability

Fees
Actual 12B-1 Fee 0.25%
Actual Management Fee 0.25%
Administration Fee 15.65K%
Maximum Front Load --
Maximum Deferred Load --
Maximum Redemption Fee --
General Availability
Available for Insurance Product Yes
Available for RRSP No
Purchase Details
Open to New Investors Yes
Minimum Initial Investment 0.00 None
Minimum Subsequent Investment 0.00 None

Basic Info

Investment Strategy
The Fund seeks to equal the performance of the Standard & Poor's MidCap 400 Composite Stock Index ("S&P MidCap 400 Index"). The Index consists of common stock of approximately 400 mid capitalization companies. The Fund seeks to purchase stock of all the companies in the Index.
General
Security Type Insurance Fund
Equity Style Small Cap Core
Broad Asset Class US Equity
Broad Category Equity
Global Peer Group Equity US Sm&Mid Cap
Peer Group S&P Midcap 400 Index Funds
Global Macro Equity North America
US Macro Mid-Cap Funds
YCharts Categorization --
YCharts Benchmark --
Prospectus Objective Mid-Cap Funds
Fund Owner Firm Name Brighthouse Financial
Broad Asset Class Benchmark Index
^SPXTR 100.0%

View Basic Info
Start Trial

Fundamentals

General
Distribution Yield --
Dividend Yield TTM (4-1-26) 0.88%
30-Day SEC Yield --
7-Day SEC Yield --
Number of Holdings 407
Stock
Weighted Average PE Ratio 31.57
Weighted Average Price to Sales Ratio 4.660
Weighted Average Price to Book Ratio 5.261
Weighted Median ROE 16.59%
Weighted Median ROA 5.79%
ROI (TTM) 9.40%
Return on Investment (TTM) 9.40%
Earning Yield 0.0451
LT Debt / Shareholders Equity 1.035
Number of Equity Holdings 401
As of February 28, 2026

Growth Metrics

EPS Growth (1Y) 18.06%
EPS Growth (3Y) 10.29%
EPS Growth (5Y) 14.73%
Sales Growth (1Y) 9.33%
Sales Growth (3Y) 7.81%
Sales Growth (5Y) 12.00%
Sales per Share Growth (1Y) 62.80%
Sales per Share Growth (3Y) 7.03%
Operating Cash Flow - Growth Rate (3Y) 20.55%
As of February 28, 2026

Fund Details

Key Dates
Launch Date 1/2/2001
Share Classes
LP40053656 A
LP40071657 Other
LP40173037 Other
Attributes
Inverse Fund No
Leveraged Fund --
Currency Hedged Fund --
Socially Responsible Fund No

Top Portfolio Holders

Name % Weight
Portfolio A 5.00%
Portfolio B 3.50%
Portfolio C 2.25%
View Top Portfolio Holders
Start Trial